Home » GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE
GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE
GlaxoSmithKline has begun distributing a medicine tagged with radio frequency identification (RFID) technology as part of a pilot project to help protect patient safety.
Finanzen.net
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May